A Clinical Study of the Effect of Estradiol Valerate on Sleep Disorders, Negative Emotions, and Quality of Life in Perimenopausal Women
Open Access
- 16 October 2021
- journal article
- retracted article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-7
- https://doi.org/10.1155/2021/8037459
Abstract
In this prospective study, we randomly divided 100 patients with perimenopausal syndrome equally into the control group (n=50) receiving conventional treatment and the study group (n=50) receiving estradiol valerate. The indicators observed were endometrial thickness, uterine volume, and the levels of LH (luteinizing hormone), FSH (follicle-stimulating hormone), and E2 (estradiol) of the patients before and after treatment. The Pittsburgh Sleep Quality Index (PSQI), Hamilton Anxiety/Depression Scale (HAMA/HAMD), Kupperman symptom score, and menopause-specific quality of life (MENQOL) were also applied to assess the sleep quality, negative emotions, severity of the condition, and quality of life of all patients, respectively. Our findings were that estradiol valerate is beneficial in improving serum sex hormone levels, sleep disturbances, negative mood, and quality of life in patients with perimenopausal syndrome and that its safety profile is high enough to warrant clinical promotion.Keywords
Funding Information
- Ningbo Municipal Bureau of Science and Technology (2019C50089)
This publication has 29 references indexed in Scilit:
- The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic SyndromePhysiology, 2016
- Treatment of chronic insomnia disorder in menopauseMenopause, 2015
- Perimenopause as a neurological transition stateNature Reviews Endocrinology, 2015
- Connections between sleep and cognition in older adultsThe Lancet Neurology, 2014
- Sleep and Alzheimer disease pathology—a bidirectional relationshipNature Reviews Neurology, 2013
- The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety–depression disorderArchiv für Gynäkologie, 2011
- A randomized, controlled pilot trial of hormone therapy for menopausal insomniaArchives of Women's Mental Health, 2011
- Depressão e ansiedade em mulheres climatéricas: fatores associadosRBGO Gynecology & Obstetrics, 2009
- Depressão e ansiedade em mulheres climatéricas: fatores associadosRBGO Gynecology & Obstetrics, 2009
- Gender differences in sleep disordersCurrent Opinion in Pulmonary Medicine, 2006